121 related articles for article (PubMed ID: 26364632)
1. RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.
Fernández-Sanlés A; Berzal-Herranz B; González-Matamala R; Ríos-Marco P; Romero-López C; Berzal-Herranz A
Molecules; 2015 Sep; 20(9):16030-47. PubMed ID: 26364632
[TBL] [Abstract][Full Text] [Related]
2. RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.
Marton S; Romero-López C; Berzal-Herranz A
J Viral Hepat; 2013 Feb; 20(2):103-12. PubMed ID: 23301545
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
[TBL] [Abstract][Full Text] [Related]
4. The HCV genome domains 5BSL3.1 and 5BSL3.3 act as managers of translation.
Romero-López C; Ríos-Marco P; Berzal-Herranz B; Berzal-Herranz A
Sci Rep; 2018 Oct; 8(1):16101. PubMed ID: 30382192
[TBL] [Abstract][Full Text] [Related]
5. Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element.
Marton S; Berzal-Herranz B; Garmendia E; Cueto FJ; Berzal-Herranz A
Pharmaceuticals (Basel); 2011 Dec; 5(1):49-60. PubMed ID: 24288042
[TBL] [Abstract][Full Text] [Related]
6. The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation.
Ríos-Marco P; Romero-López C; Berzal-Herranz A
Sci Rep; 2016 May; 6():25729. PubMed ID: 27165399
[TBL] [Abstract][Full Text] [Related]
7. EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication.
Oakland TE; Haselton KJ; Randall G
J Virol; 2013 Jun; 87(12):6625-34. PubMed ID: 23552423
[TBL] [Abstract][Full Text] [Related]
8. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
[TBL] [Abstract][Full Text] [Related]
11. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.
Jones LA; Clancy LE; Rawlinson WD; White PA
Antimicrob Agents Chemother; 2006 Sep; 50(9):3019-27. PubMed ID: 16940097
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.
Watashi K; Ishii N; Hijikata M; Inoue D; Murata T; Miyanari Y; Shimotohno K
Mol Cell; 2005 Jul; 19(1):111-22. PubMed ID: 15989969
[TBL] [Abstract][Full Text] [Related]
13. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
14. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
Molecules; 2017 May; 22(5):. PubMed ID: 28531161
[TBL] [Abstract][Full Text] [Related]
15. Isolation of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2007; (51):393-4. PubMed ID: 18029752
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel RNA secondary structures within the hepatitis C virus genome reveals a cooperative involvement in genome packaging.
Stewart H; Bingham RJ; White SJ; Dykeman EC; Zothner C; Tuplin AK; Stockley PG; Twarock R; Harris M
Sci Rep; 2016 Mar; 6():22952. PubMed ID: 26972799
[TBL] [Abstract][Full Text] [Related]
17. The chaperone-like activity of the hepatitis C virus IRES and CRE elements regulates genome dimerization.
Romero-López C; Barroso-delJesus A; Berzal-Herranz A
Sci Rep; 2017 Feb; 7():43415. PubMed ID: 28233845
[TBL] [Abstract][Full Text] [Related]
18. Subgenomic replicon derived from a cell line infected with the hepatitis C virus.
Kishine H; Sugiyama K; Hijikata M; Kato N; Takahashi H; Noshi T; Nio Y; Hosaka M; Miyanari Y; Shimotohno K
Biochem Biophys Res Commun; 2002 May; 293(3):993-9. PubMed ID: 12051758
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus production by aptamers against the core protein.
Shi S; Yu X; Gao Y; Xue B; Wu X; Wang X; Yang D; Zhu H
J Virol; 2014 Feb; 88(4):1990-9. PubMed ID: 24307579
[TBL] [Abstract][Full Text] [Related]
20. Potential of the Other Genetic Information Coded by the Viral RNA Genomes as Antiviral Target.
Berzal-Herranz A; Romero-López C; Berzal-Herranz B; Ramos-Lorente S
Pharmaceuticals (Basel); 2019 Mar; 12(1):. PubMed ID: 30871174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
